Bioavailability of phytochemical constituents from a novel soy fortified lycopene rich tomato juice developed for targeted cancer prevention trials

Nutrition and Cancer

Volumn 65, Issue 6, 2013, Pages 919-929

  Bohn, Torsten ^a,b   Blackwood, Michelle ^a   Francis, David ^a   Tian, Qingguo ^a   Schwartz, Steven J ^a   Clinton, Steven K ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLDAIDZIN; ACETYLGENISTIN; ACETYLGLYCITIN; ALPHA TOCOPHEROL DERIVATIVE; BETA CAROTENE; BETA TOCOPHEROL; BIOLOGICAL MARKER; CAROTENOID; DAIDZEIN; DELTA TOCOPHEROL; EQUOL; GENISTEIN; GLYCITEIN; GLYCITIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYCOPENE; MALONYLDAIDZIN; MALONYLGENISTIN; MALONYLGLYCITIN; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BIOLOGICAL ACTIVITY; CANCER PREVENTION; DRUG BIOAVAILABILITY; FEMALE; HUMAN; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; OXIDATION; OXIDATIVE STRESS; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PHYTOCHEMISTRY; SOYBEAN; TOMATO;

EID: 84882410814     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2011.630156     Document Type: Article

References (59)

1. Willcox JK, Catignani GL, and Lazarus S: Tomatoes and cardiovascular health. Crit Rev Food Sci Nutr 43, 1-18, 2003.
2. Palozza P, Parrone N, Catalano A, and Simone R: Tomato lycopene and inflammatory cascade: Basic interactions and clinical implications. Curr Med Chem 17, 2547-2563, 2010.
3. Clinton SK: Tomatoes or lycopene: A role in prostate carcinogenesis? J Nutr 135, 2057S-2059S, 2005.
4. Giovannucci E: Tomato products, lycopene, and prostate cancer: A review of the epidemiological literature. J Nutr 135, 2030S-2031S, 2005.
5. Fleshner N and Zlotta AR: Prostate cancer prevention: Past, present, and future. Cancer 110, 1889-1899, 2007.
6. Boileau TW, Liao Z, Kim S, Lemeshow S, Erdman JW, Jr., et al.: Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. J Natl Cancer Inst 95, 1578-1586, 2003.
7. Canene-Adams K, Campbell JK, Zaripheh S, Jeffery EH, and Erdman JW, Jr.: The tomato as a functional food. J Nutr 135, 1226-1230, 2005.
8. McDaniel MR, and Chan N: Masking of soy protein flavor by tomato sauce. J Food Sci 53, 93-98, 1988.
9. Bohn T: Bioavailability of non-provitamin A carotenoids. Curr Nutr Food Sci 4, 240-258, 2008.
10. Unlu NZ, Bohn T, Clinton SK, and Schwartz SJ: Carotenoid absorption from salad and salsa by humans is enhanced by the addition of avocado or avocado oil. J Nutr 135, 431-436, 2005.
11. Wang S, DeGroff VL, and Clinton SK: Tomato and soy polyphenols reduce insulin-like growth factor-I-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase. J Nutr 133, 2367-2376, 2003.
12. Hwang YW, Kim SY, Jee SH, Kim YN, and Nam CM: Soy food consumption and risk of prostate cancer: A meta-analysis of observational studies. Nutr Cancer 61, 598-606, 2009.
13. Jian L: Soy, isoflavones, and prostate cancer. Mol Nutr Food Res 53, 217-226, 2009.
14. Zhan S and Ho SC: Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81, 397-408, 2005.
15. Xiao CW: Health effects of soy protein and isoflavones in humans. J Nutr 138, 1244S-1249S, 2008.
16. Andres S, Abraham K, Appel KE, and Lampen A: Risks and benefits of dietary isoflavones for cancer. Crit Rev Toxicol 41, 463-506, 2011.
17. van Erp-Baart MAJ, Brants HAM, Kiely M, Mulligan A, Turrini A, et al.: Isoflavone intake in four different European countries: The VENUS approach. Br J Nutr 89, S25-S30, 2003.
18. Zhang YC, Albrecht D, Bomser J, Schwartz SJ, and Vodovotz Y: Isoflavone profile and biological activity of soy bread. J Agric Food Chem 51, 7611-7616, 2003.
19. Steinberg FM: Soybeans or soymilk: Does it make a difference for cardiovascular protection? Does it even matter? Am J Clin Nutr 85, 927-928, 2007.
20. Gonzalezgalan A,Wang SH, Sgarbieri VC, andMoraes MAC: Sensory and nutritional properties of cookies based on wheat-rice-soybean flours baked in a microwave-oven. J Food Sci 56, 1699-1703, 1991.
21. Schultz S: Pass the tofu tacos. Soy-based foods are disease fighters, but they can taste pretty weird. US News World Rep 127, 77-78, 1999.
22. Terhaar Sive Droste JS, Tuynman JB, Van Dullemen HM, and Mulder CJ: Chemoprevention for colon cancer: New opportunities, fact or fiction? Scand J Gastroenterol (Suppl 243), 158-164, 2006.
23. Katdare M, Kopelovich L, and Telang N: Efficacy of chemopreventive agents for growth inhibition of Apc [+/-] 1638NCOL colonic epithelial cells. Int J Mol Med 10, 427-432, 2002.
24. Grainger EM, Schwartz SJ, Wang S, Unlu NZ, Boileau TW, et al.: A combination of tomato and soy products for men with recurring prostate cancer and rising prostate specific antigen. Nutr Cancer 60, 145-154, 2008.
25. FDA: CFR 170.3: Code of Federal Regulations, Title 21, Vol. 3. Joint Committee on Printing of the United States Congress, Washington DC, 2003.
26. Tiziani S and Vodovotz Y: Rheological characterization of a novel functional food: Tomato juice with soy germ. J Agric Food Chem 53, 7267-7273, 2005.
27. Xu SY, Shoemaker CF, and Luh BS: Effect of break temperature on rheological properties and microstructure of tomato juices and pastes. J Food Sci 51, 399-402, 1986.
28. Brown MJ, Ferruzzi MG, Nguyen ML, Cooper DA, Eldridge AL, et al.: Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection. Am J Clin Nutr 80, 396-403, 2004.
29. Franke AA, Custer LJ, Tanaka Y,Messina M, and Erdman JW: Isoflavones in human breast milk and other biological fluids. Am J Clin Nutr 68, 1466S-1473S, 1998.
30. Ferruzzi MG, Nguyen ML, Sander LC, Rock CL, and Schwartz SJ: Analysis of lycopene geometrical isomers in biological microsamples by liquid chromatography with coulometric array detection. J Chromatogr B 760, 289-299, 2001.
31. van den Berg H and van Vliet T: Effect of simultaneous, single oral doses of beta-carotene with lutein or lycopene on the beta-carotene and retinyl ester responses in the triacylglycerol-rich lipoprotein fraction of men. Am J Clin Nutr 68, 82-89, 1998.
32. Hadley CW, Clinton SK, and Schwartz SJ: The consumption of processed tomato products enhances plasma lycopene concentrations in association with a reduced lipoprotein sensitivity to oxidative damage. J Nutr 133, 727-732, 2003.
33. Popov INand Lewin G: Photochemiluminescent detection of antiradical activity.4. Testing of lipid-soluble antioxidants. J Biochem Biophys Methods 31, 1-8, 1996.
34. National Cancer Institute: Common Terminology Criteria for Adverse Events, Version 3.0. U.S. Department of Health and Human Services, National Institutes of Health, Bethesda, MD, 2003.
35. O'Neill ME and Thurnham DI: Intestinal absorption of beta-carotene, lycopene and lutein in men and women following a standard meal: Response curves in the triacylglycerol-rich lipoprotein fraction. Br J Nutr 79, 149-159, 1998.
36. Setchell KD, BrownNM, and Lydeking-Olsen E: The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132, 3577-3584, 2002.
37. Unlu NZ, Bohn T, Francis D, Clinton SK, and Schwartz SJ: Carotenoid absorption in humans consuming tomato sauces obtained from tangerine or high-beta-carotene varieties of tomatoes. J Agric Food Chem 55, 1597-1603, 2007.
38. Unlu NZ, Bohn T, Francis DM, Nagaraja HN, Clinton SK, et al.: Lycopene from heat-induced cis-isomer-rich tomato sauce is more bioavailable than from all-trans-rich tomato sauce in human subjects. Br J Nutr 98, 1-7, 2007.
39. Munro IC, Harwood M, Hlywka JJ, Stephen AM, Doull J, et al.: Soy isoflavones: A safety review. Nutr Rev 61, 1-33, 2003.
40. Shao A and Hathcock JN: Risk assessment for the carotenoids lutein and lycopene. Regul Toxicol Pharmacol 45, 289-298, 2006.
41. Gustin DM, Rodvold KA, Sosman JA, Diwadkar-Navsariwala V, Stacewicz-Sapuntzakis M, et al.: Single-dose pharmacokinetic study of lycopene delivered in a well-defined food-based lycopene delivery system (tomato paste-oilmixture) in healthy adultmale subjects. Cancer Epidemiol Biomarkers Prev 13, 850-860, 2004.
42. Frohlich K, Kaufmann K, Bitsch R, and Bohm V: Effects of ingestion of tomatoes, tomato juice and tomato puree on contents of lycopene isomers, tocopherols and ascorbic acid in human plasma as well as on lycopene isomer pattern. Br J Nutr 95, 734-741, 2006.
43. Riso P, Brusamolino A, Martinetti A, and Porrini M: Effect of a tomato drink intervention on insulin-like growth factor (IGF)-1 serum levels in healthy subjects. Nutr Cancer 55, 157-162, 2006.
44. Cohn W, Thurmann P, Tenter U, Aebischer C, Schierle J, et al.: Comparative multiple dose plasma kinetics of lycopene administered in tomato juice, tomato soup or lycopene tablets. Eur J Nutr 43, 304-312, 2004.
45. Richelle M, Pridmore-Merten S, Bodenstab S, Enslen M, and Offord EA: Hydrolysis of isoflavone glycosides to aglycones by beta-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women. J Nutr 132, 2587-2592, 2002.
46. Franke AA, Custer LJ, and Hundahl SA: Determinants for urinary and plasma isoflavones in humans after soy intake. Nutr Cancer 50, 141-154, 2004.
47. Bohn T: Isoflavonoid bioavailability from foods and supplements: Dietary factors impacting utilization. Agro Food Industry Hi-Tech 21, 59-63, 2010.
48. Walsh KR, Zhang YC, Vodovotz Y, Schwartz SJ, and Failla ML: Stability and bioaccessibility of isoflavones from soy bread during in vitro digestion. J Agric Food Chem 51, 4603-4609, 2003.
49. Setchell KD, Faughnan MS, Avades T, Zimmer-Nechemias L, Brown NM, et al.: Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am J Clin Nutr 77, 411-419, 2003.
50. Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L,Wolfe BE, et al.: Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 131, 1362S-1375S, 2001.
51. Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, et al.: Comparisons of percent equol producers between prostate cancer patients and controls: Case-controlled studies of isoflavones in Japanese, Korean, and American residents. Jpn J Clin Oncol 34, 86-89, 2004.
52. Frankenfeld CL, Atkinson C, Thomas WK, Gonzalez A, Jokela T, et al.: High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart. Br J Nutr 94, 873-876, 2005.
53. Caan BJ, Natarajan L, Parker B, Gold EB, Thomson C, et al.: Soy food consumption and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev 20, 854-858, 2011.
54. Das S, Otani H,Maulik N, and Das DK: Lycopene, tomatoes, and coronary heart disease. Free Radic Res 39, 449-455, 2005.
55. Liu J, Chang SK, and Wiesenborn D: Antioxidant properties of soybean isoflavone extract and tofu in vitro and in vivo. J Agric Food Chem 53, 2333-2340, 2005.
56. Mackinnon ES, Rao AV, Josse RG, and Rao LG: Supplementation with the antioxidant lycopene significantly decreases oxidative stress parameters and the bone resorption marker N-telopeptide of type I collagen in postmenopausal women. Osteoporos Int 22, 1091-1101, 2011.
57. Sirtori CR, Arnoldi A, and Johnson SK: Phytoestrogens: End of a tale? Ann Med 37, 423-438, 2005.
58. Meng QH, Lewis P, Wahala K, Adlercreutz H, and Tikkanen MJ: Incorporation of esterified soybean isoflavones with antioxidant activity into low density lipoprotein. Biochim Biophys Acta 1438, 369-376, 1999.
59. Bouayed J and Bohn T: Exogenous antioxidants-double-edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses. Ox Med Cell Longev 3, 228-237, 2010.